UK markets closed
NIKKEI 225
27,999.96 -249.28 (-0.88%) HANG SENG
20,003.44 -42.33 (-0.21%) CRUDE OIL
90.54 -0.22 (-0.24%) GOLD FUTURES
1,792.40 +5.60 (+0.31%) DOW
32,774.41 -58.13 (-0.18%) BTC-GBP
19,193.36 -681.49 (-3.43%)
CARA Jan 2024 2.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:40AM EDT. Market open.
| Previous close | 0.4000 |
| Open | 0.4000 |
| Bid | 0.0000 |
| Ask | 5.0000 |
| Strike | 2.50 |
| Expiry date | 2024-01-19 |
| Day's range | 0.4000 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
- Zacks
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of 71.43% and 8.08%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Should You Buy Cara Therapeutics (CARA) Ahead of Earnings?
Cara Therapeutics (CARA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
Investors in Cara Therapeutics (NASDAQ:CARA) have unfortunately lost 56% over the last three years
Cara Therapeutics, Inc. ( NASDAQ:CARA ) shareholders should be happy to see the share price up 18% in the last month...
© 2022 Yahoo. All rights reserved.
